MIT 1000 Rapid Microbial Identification System Successfully Identifies Japanese Bacteria Strains

SAN CLEMENTE, CA--(Marketwire - December 4, 2007) - Micro Imaging Technology, Inc. (OTCBB: MMTC) announces successful completion of validation tests for Yotsubishi Corporation of Tokyo, Japan. Tests performed by MIT have successfully identified selected strains of NBRC bacteria (E.coli, Staphylococcus aureus, and Staphylococcus epidermidis) using the MIT 1000 rapid microbial identification system. NBRC is the Japanese National Institute of Technology and Evaluation Biological Resource Center. Yotsubishi recently purchased two MIT 1000 Systems through its distributor, K.T. Yoke, with the goal of selling numerous systems throughout Japan and South Korea.

Michael Brennan, Chairman and CEO of Micro Imaging Technology, stated, "We are excited about the opportunities with Yotsubishi. Now that we have successfully demonstrated our system's ability to identify the various strains of bacteria they have selected, we anticipate favorable results will be obtained in any future specific application testing. We believe that the distribution channels of Yotsubishi will lead to a significant number of sales in 2008 and beyond."

About Yotsubishi:

Yotsubishi is a subsidiary of Sibata Scientific Technology, a leading supplier of laboratory and environmental equipment in Japan employing over 270 people. The company is both ISO and OHSAS (Occupational Health & Safety Management Systems) certified. In business for over 85 years, Sibata has worldwide sales and service and is engaged in discussions with several companies in food processing and research labs that are expected to result in sales during 2008.

About Micro Imaging Technology

The Company has developed and patented a technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is non-biological and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis.

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, Shigella and other pathogenic bacteria. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The Test Report, in the Company's opinion, demonstrated the accuracy, speed and efficiency of the MIT system over conventional processes and is available from the Company. The MIT 1000 System was recently featured in the Rapid Microbiology international newsletter. The article can be viewed at www.rapidmicrobiology.com/news/1231h0.php

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Contact Information: CONTACT: Michael Brennan Chairman Email: Telephone: (805) 557-0614